Type 2 diabetes is associated with cognitive dysfunction and structural brain changes.
Abnormalities in glucose regulation are involved in several complications related to type 2 …

Type 2 diabetes is associated with dementia, and also with more slight cognitive
decrements. In this Review we discuss trajectories from normal cognition to dementia in …

Background: Optimal treatment to prevent or delay cognitive decline, mild cognitive
impairment (MCI), or dementia is uncertain. Purpose: To summarize current evidence on the …

Older people with type 2 diabetes are at increased risk of developing cognitive impairment,
for which several potential risk factors have been proposed. The present article reviews …

Introduction Few studies have examined memory decline among patients with type 2
diabetes using different oral hypoglycemic drugs. Methods Participants with normal …

Type 2 diabetes is a metabolic disease characterised by insulin resistance with
hyperglycaemia and dyslipidaemia. It is associated with increased risk of stroke and …

The prevalence of type 2 diabetes mellitus (DM2) increases markedly with age. Antidiabetic
treatment and the objectives of glycaemic control in elderly patients with DM2 should be …

La prevalencia de la diabetes mellitus tipo 2 (DM2) se incrementa marcadamente con la
edad. El tratamiento antidiabético y los objetivos de control glucémico en el anciano con …

Diabetes mellitus is a potent upstream event in the molecular pathophysiology which gives
rise to various diabetes-related complications. There are several classes of anti-diabetic …

The prevalence of type 2 diabetes mellitus (T2DM) is increasing in the elderly. Because of
the unique characteristics of elderly people with T2DM, therapeutic strategy and focus …